Authors: VICENT JM APARICIO J LIZON J MOLINS C ALONSO JD GIMENEZARNAU JM CAMPS C SEGURA A RIZO A XARLES J

Citation: Jm. Vicent et al., PHASE-II TRIAL OF IRINOTECAN (CPT-11) IN PATIENTS WITH 5-FU RESISTANTADVANCED COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 210-210

Authors: ABAD A MASSUTI B BLANCO E CARRATO A MAUREL J CERVANTES A ARANDA E ANTON A VICENT JM DORTA J DEPAREDES MLG ARIZA A

Citation: A. Abad et al., 72 HOUR EPIRUBICIN INFUSION PLUS QUINIDINE IN UNRESECTABLE AND METASTATIC ADENOCARCINOMA OF THE PANCREAS - A PHASE-II TRIAL, American journal of clinical oncology, 21(2), 1998, pp. 151-154

Authors: FELIU J BARON MG GIRON CG ESPINOSA E VICENT JM NAVARRO JG BERROCAL A ORDONEZ A VILCHES Y DECASTRO J DIAZ J

Citation: J. Feliu et al., PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN IN INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, American journal of clinical oncology, 19(6), 1996, pp. 577-580

Authors: TARIN F CAMPS C BERROCAL A VICENT JM

Citation: F. Tarin et al., PANCREATITIS FOLLOWING CISPLATIN AND VIND ESIN, Revista espanola de enfermedades digestivas, 85(3), 1994, pp. 224-225

Authors: ABAD A MASUTI B CAMPS C FONT A BALANA C VICENT JM SANCHEZ JJ

Citation: A. Abad et al., EPIRUBICIN PLUS A CALMODULIN INHIBITOR (TRIFLUOPERAZINE) ACTIVITY IN ADVANCED PANCREATIC ADENOCARCINOMA, European journal of cancer, 30A(7), 1994, pp. 1043-1044